A XM não fornece serviços a residentes nos Estados Unidos da América.

Growth is missing piece in UBS valuation puzzle



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Growth is missing piece in UBS valuation puzzle</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Liam Proud

LONDON, Aug 14 (Reuters Breakingviews) -UBS UBSG.S boss Sergio Ermotti faces two big questions. Can he successfully integrate Credit Suisse, which his bank acquired last year in a state-backed rescue, and can he prove that the combined group has a reliable growth engine? Based on the bank’s most recent results, he’s convincing on the first point but less so on the second. That uncertainty will keep the $100 billion group’s valuation in check.

UBS is successfully shrinking the old Credit Suisse investment bank. The so-called non-core division should house just $48 billion of risk-weighted assets by the end of 2024, a 44% reduction from last summer’s level. The unit’s traders, under Beatriz Martin Jimenez, also appear to be exiting old Credit Suisse positions at a profit, since the division is also generating revenues.

Meanwhile, Ermotti is upping the pace of the integration. He added an extra $500 million to the cost cuts he plans to make this year, meaning that by the end of December he should be over halfway towards his overall 2026 savings target of $13 billion. The only quibble is how much of the benefit will drop down to UBS’s bottom line. Ermotti has so far failed to put a number on the proportion of savings he will use to fund investments.

The bigger question, though, is growth. The core wealth business and domestic Swiss bank both posted lower revenue in the second quarter of 2024 than in the first. Some of the factors may be temporary: rich clients are making fewer transactions, for example. And Ermotti can boast that the wealth unit saw $27 billion of net asset inflows in the second quarter – even as rival Morgan Stanley’s MS.N equivalent figure slumped.

Still, the growth rates for asset inflows in that key business are hardly inspiring at around 2% to 3% in recent quarters, partly because the division has been dumping less profitable clients. Ermotti wants to turbocharge things eventually, with a target of eventually grabbing $200 billion of net new assets a year by 2028. But it’s unclear exactly how he plans to do this. In any case, that goal is less than the equivalent inflow number that analysts are pencilling in for Morgan Stanley this year.

The gap arguably makes UBS’s valuation multiple of roughly 1 times forward tangible book value seem fair, even though wealth rivals like Morgan Stanley and Julius Baer BAER.S trade at 2 or 3 times, based on LSEG Datastream figures. For Ermotti, boosting the multiple means showing that he can also boost the top line.

Follow @Breakingviews on X


CONTEXT NEWS

UBS on Aug. 14 reported $11.1 billion of underlying revenue for the second quarter of 2024, up 10% year-on-year and down 7% compared with the first quarter. The bank’s underlying figures exclude integration-related one-offs from its acquisition of Credit Suisse in 2023.

The bank said that it expects to have cut $7 billion of costs because of the merger by the end of 2024, compared with a previous target of $6.5 billion.

It also increased the pace of its run-off of risk-weighted assets (RWAs) from the non-core and legacy unit, which is effectively the assets in the old Credit Suisse investment bank that UBS plans to either sell or let expire. RWAs will be $48 billion by the end of 2024 and $37 billion by the end of 2025, compared with previous targets of $56 billion and $45 billion, respectively.

Shares in UBS were up 2.35% to 25.71 Swiss francs as of 0750 GMT on Aug. 14.


UBS's uninspiring asset growth rate in the global wealth unit https://reut.rs/3M3PGEE


Editing by Aimee Donnellan and Streisand Neto

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.